Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
 
Survey
We asked 60 industry leaders, What impact do mega-mergers of biopharmaceutical companies
have on the development of new drugs?

Improves the quality and number of innovative drugs available to patients 29%

Restricts innovation and the development of new drugs

54%
Has no impact on drug development 4%
Don't know 13%
 

Talk to us:
jupton@advanstar.com

Advertise with us:
wblow@advanstar.com

19 Aug, 2014
TTIP: From Hot Tip to Oblivion?
The Transatlantic Trade and Investment Partnership (TTIP) was the hot tip for a 2014 success story. But as summer slides away, the latest read-out of progress suggests that rather than remaining a hot tip, TTIP is now risking oblivion, writes Reflector. Read more
Ebola Outbreak Raises Ethical Issues
The development of new treatments and preventives to combat the lethal Ebola virus has been slow, marked by caution at public health agencies to approve testing of high-risk compounds, and reluctance of biopharmaceutical companies to invest in a field with limited market potential. All that has changed now. Jill Wechsler reports on the global efforts to facilitate access to experimental drugs and vaccines... Read more
Mind the (Generation) Gap: The Hunt for Talent in Asia-Pac
As more global life sciences firms see their Asian businesses skyrocket, the search for strong, internationally savvy talent in Asia-Pacific has never been more competitive. Susan Macdonald talks to Thomas Meininghaus of Siemens Audiology Solutions about the unique challenges of recruiting to fill senior roles in Asia ... Read more
Pharm Exec’s Emerging Pharma Leaders 2014
This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise — all binded by an underlying commitment to the patient.... Read more
A Window on the Industry: This Year’s Emerging Pharma Leaders
Pharm Exec's 2014 roster of emerging pharma leaders serves as a window on work in an industry that relies on human capital as the coinage of success, writes William Looney.... Read more
Also in this issue
Pharm Exec 2014 Dealmakers Outlook
M&As: Past, Present, and Future
Apple or Big Pharma: Who Will Win in the Healthcare Wearables Space?
Pharm Exec eBooks Available as Apps